n one of several broad spectrum antibiotic substances obtained from fungi and related to penicillin (trade names Mefoxin); addition of side chains has produced semisynthetic antibiotics with greater antibacterial activity
Cubist Pharmaceuticals rallies as antibiotic candidate hits endpoint Cubist Pharmaceuticals ( CBST ) is out with top-line data from a pivotal study of ceftolozane/tazobactam in complicated intra-abdominal infections. The company says the Phase 3 trial met the FDA and EMA's primary endpoint (non-inferiority to meropenem). AE profile is "consistent with that seen with other cephalosporin antibiotics and comparable to meropenem." NDA expected in H1 2014. MAA ...
Dec. 16, 2013 - Seeking Alpha